Featured post

Alliance for the Treatment of Intractable Pain (ATIP)

Together with several of his colleagues in the battle for pain patients’ rights, Richard “Red” Lawhern, Ph.D. recently unveiled a new organization,

Alliance for the Treatment of Intractable Pain (ATIP)
ATIP on Facebook

This is a group of and for people willing to take an active part in changing the rules about pain treatment in this country, starting with lobbying to reject/repeal/replace the unscientific and biased CDC Opioid Prescribing Guideline. 

If you’re looking for a way to make your voice heard, ATIP can help you channel it effectively.  Continue reading


A Modern-Day Physician’s Pledge

The Revised Declaration of Geneva: A Modern-Day Physician’s Pledge Oct 2017

A newly revised version of the Declaration of Geneva was adopted by the World Medical Association (WMA) General Assembly on October 14, 2017, in Chicago.

As the contemporary successor to the 2500-year-old Hippocratic Oath, the Declaration of Geneva, which was adopted by the World Medical Association (WMA) at its second General Assembly in 1948, outlines in concise terms the professional duties of physicians and affirms the ethical principles of the global medical profession.   Continue reading

Why evidence-based healthcare has lost its way

Why evidence-based healthcare has lost its way – Roger Kerry – Oct 2017

Without evidence-based healthcare, medicine is not much better than folklore.

In the bad old days, clinical decisions were based largely on the experience and wisdom of doctors and other healthcare professionals, but treatments given in this manner sometimes did more harm than good.

Evidence-based healthcare (EBHC) on the other hand uses population data to figure out the best treatments for different illnesses.   Continue reading

Pain Ed for Professionals from a Lay Perspective

Trust me, I’m a patient: pain education for professionals from a lay perspective – Br J Pain. 2012 May – Dorothy Helme – Lay member, British Pain Society Patient Liaison Committee.

A young woman with arthritis talking about the rising tide of hostility to disability claimants says: ‘People think I’m faking. I’ve lost friends over it. Pain is invisible and hard for people to understand.’ How many of us could say that we have never thought that someone reporting pain is faking or, at the very least, making too much fuss?

This is the society in which we live: intolerant of the pain of others.  Continue reading

Off-Label Prescribing of Fentanyl Products

DEA Begins Targeting Off-Label Prescribing of TIRF Products – Pain Medicine News – Oct 2017 – Ronald W. Chapman II, Esq.

TIRF = Transmucosal Immediate-Release Fentanyl

Traditionally, the decision whether to prescribe a certain medication off-label or not is reserved for the independent judgment of the physician and the specific needs of the patient.

Off-label uses of prescription medication are not regulated by the FDA and may be employed as long as the prescription is within the standard of care and is prescribed in the usual course of professional practice and for a legitimate medical purpose.

Recently, however, the Drug Enforcement Administration (DEA) has initiated criminal and administrative action against physicians who prescribe opioids, such as transmucosal immediate-release fentanyl (TIRF), off-label for the treatment of breakthrough pain Continue reading

US ‘opioid crisis’ – prescriptions aren’t the problem

The truth about the US ‘opioid crisis’ – prescriptions aren’t the problem | Marc Lewis | Opinion | The Guardian – Nov 2017

The news media is awash with hysteria about the opioid crisis (or opioid epidemic). But what exactly are we talking about?

If you Google “opioid crisis”, nine times out of 10 the first paragraph of whatever you’re reading will report on death rates. That’s right, the overdose crisis.

Is the opioid crisis the same as the overdose crisis? No. One has to do with addiction rates, the other with death rates. And addiction rates aren’t rising much, if at all, except perhaps among middle-class whites.   Continue reading

Quality of Life in Joint Hypermobility Syndrome/EDS

Systemic Manifestations and Health-Related Quality of Life in Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-Hypermobility Type – Sydney Medical School, Discipline of Biomedical Science – Krahe, Anne 

Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-Hypermobility Type (JHS/EDS-HT) is a hereditary connective tissue disorder associated with both musculoskeletal and systemic manifestations.

There is increasing recognition of the significance of the non-musculoskeletal manifestations of the disorder, such as

  • fatigue,
  • orthostatic intolerance,
  • gastrointestinal symptoms and
  • psychological features, Continue reading

BOHICA: New Joint Commission Pain Standards

New Joint Commission Pain Standards a Good Start, but Devil’s in the Details: Experts – Pain Medicine News – Nov 2017 —Ajai Raj 

Bend over, here it comes again…

The Joint Commission described the new standards in its “Requirement, Rationale, Reference” (R3) report, released on Aug. 29, 2017, writing that they are “designed to improve the quality and safety of care provided by Joint Commission–accredited hospitals.”

And, of course, quality in pain treatment is currently defined by how much they can reduce (or deny outright) opioid pain relievers.  Continue reading

Routine bumps causing major injury

Routine bumps injured her joints, but finding the reason took half a century

Louise Carroll was just 7 years old when an accidental bump into a sofa turned into a major injury. Most kids might have ended up with a bruise or a scrape; Carroll dislocated her knee. Then she popped it back into place.

That is Carroll’s first memory of what would become a common occurrence: An everyday mishap causing major, and painful, damage to her knees, wrists, and other joints. Yet it took half a century — and consultations with doctors on the other side of the globe — to figure out why Carroll, now 59, was so prone to injury.

Just reading this far, I already suspected EDS. Carroll’s story is the typically sad and frustrating experience many with EDS have to suffer through.   Continue reading

Electroceuticals: the Shocking Future of Brain Zapping

Electroceuticals: the Shocking Future of Brain Zapping: Could electrical currents replace Big Pharma? – Beenish Ahmed and Eric Elder – Mar 10 2015

It’s all in your head—those icky feelings, all that fog—and chemicals just aren’t that great at cutting through. That’s why scientists are experimenting with changing the brain game by tweaking its circuitry, rather than the chemical processes.

It might be a bit unnerving to us seasoned pill-poppers, but some believe that electrical currents could be the new wave in everything cerebral, from treating depression and addiction to enhancements that would enable those seeking that mental edge to learn new skills faster or remember more.

While pharmaceutical companies rake in nearly $90 billion a year from global sales of mental health meds, psychopharmacology research and development has slowed to a crawl.   Continue reading